Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach

The prevalence of tobacco use in people with schizophrenia is much higher than in general population, which indicates a close relationship between nicotine addiction and schizophrenia. However, the molecular mechanism underlying the high comorbidity of tobacco smoking and schizophrenia remains largely unclear. In this study, we conducted a pathway and network analysis on the genes potentially associated with nicotine addiction or schizophrenia to reveal the functional feature of these genes and their interactions. Of the 276 genes associated with nicotine addiction and 331 genes associated with schizophrenia, 52 genes were shared. From these genes, 12 significantly enriched pathways associated with both diseases were identified. These pathways included those related to synapse function and signaling transduction, and drug addiction. Further, we constructed a nicotine addiction-specific and schizophrenia-specific sub-network, identifying 11 novel candidate genes potentially associated with the two diseases. Finally, we built a schematic molecular network for nicotine addiction and schizophrenia based on the results of pathway and network analysis, providing a systematic view to understand the relationship between these two disorders. Our results illustrated that the biological processes underlying the comorbidity of nicotine addiction and schizophrenia was complex, and was likely induced by the dysfunction of multiple molecules and pathways.

[1]  Jianmin Wu,et al.  PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..

[2]  S. Maloney,et al.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis. , 2015, World journal of psychiatry.

[3]  C. Hoggart,et al.  Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases , 2009, PloS one.

[4]  Margit Burmeister,et al.  New insights into the genetics of addiction , 2009, Nature Reviews Genetics.

[5]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[6]  A. Craig,et al.  Rapid Synaptic Remodeling by Protein Kinase C: Reciprocal Translocation of NMDA Receptors and Calcium/Calmodulin-Dependent Kinase II , 2002, The Journal of Neuroscience.

[7]  J. Vincent,et al.  Association of α4β2 nicotinic receptor and heavy smoking in schizophrenia , 2007 .

[8]  Robert C. Smith,et al.  Effects of Cigarette Smoking and Nicotine Nasal Spray on Psychiatric Symptoms and Cognition In Schizophrenia , 2002, Neuropsychopharmacology.

[9]  S. Gallinger,et al.  Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk , 2013, Molecular carcinogenesis.

[10]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[11]  N. Volkow.  Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity , 2009, Schizophrenia bulletin.

[12]  D. Haleem.  Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia. , 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[13]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[14]  L. Dixon,et al.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes , 1999, Schizophrenia Research.

[15]  Denise Juliano-Bult,et al.  Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. , 2015, General hospital psychiatry.

[16]  Veena Kumari,et al.  Nicotine use in schizophrenia: The self medication hypotheses , 2005, Neuroscience & Biobehavioral Reviews.

[17]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[18]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[19]  D. Weinberger,et al.  Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.

[20]  Christian Lüscher,et al.  The synapse: center stage for many brain diseases , 2009, The Journal of physiology.

[21]  Ming D. Li,et al.  Significant Association of Catechol-O-Methyltransferase (COMT) Haplotypes with Nicotine Dependence in Male and Female Smokers of Two Ethnic Populations , 2006, Neuropsychopharmacology.

[22]  S. Leonard.  Consequences of low levels of nicotinic acetylcholine receptors in schizophrenia for drug development , 2003 .

[23]  V. Knott,et al.  Acute Nicotine Alteration of Sensory Memory Impairment in Smokers With Schizophrenia , 2010, Journal of Clinical Psychopharmacology.

[24]  J. Gingrich,et al.  Src in synaptic transmission and plasticity , 2004, Oncogene.

[25]  David C. Wilson,et al.  Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. , 2009, American journal of human genetics.

[26]  Lauren M. Hickling,et al.  Tobacco smoking and its association with cognition in first episode psychosis patients , 2017, Schizophrenia Research.

[27]  Zhongming Zhao,et al.  Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci. , 2014, Schizophrenia bulletin.

[28]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[29]  R. Murray,et al.  The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services , 2017, Schizophrenia Research.

[30]  A. McCloughen.  The association between schizophrenia and cigarette smoking: a review of the literature and implications for mental health nursing practice. , 2003, International journal of mental health nursing.

[31]  Ming D. Li,et al.  Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation , 2010, Neuropsychopharmacology.

[32]  J. Suvisaari,et al.  Lifetime prevalence of psychotic and bipolar I disorders in a general population. , 2007, Archives of general psychiatry.

[33]  J. Kelsoe,et al.  Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia , 2014, Schizophrenia Research.

[34]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[35]  S. Matthysse,et al.  Neurotransmitter Theories of Schizophrenia , 1978 .

[36]  P. Batel.  Addiction and schizophrenia , 2000, European Psychiatry.

[37]  Erin Walker,et al.  Cortical opioid markers in schizophrenia and across postnatal development. , 2012, Cerebral cortex.

[38]  Michael Kohl,et al.  Cytoscape: software for visualization and analysis of biological networks. , 2011, Methods in molecular biology.

[39]  A. Markou,et al.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits , 2012, Neuropharmacology.

[40]  Lihua Zhang,et al.  Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach , 2014, Molecular Neurobiology.

[41]  Sarah M. Hartz,et al.  Genetic correlation between smoking behaviors and schizophrenia , 2017, Schizophrenia Research.

[42]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[43]  H. Nybäck,et al.  Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls , 2005, European Psychiatry.

[44]  L. W. Thompson.  The dopamine hypothesis of schizophrenia. , 2009, Perspectives in psychiatric care.

[45]  J. Yakel,et al.  Nicotinic ACh receptors as therapeutic targets in CNS disorders. , 2015, Trends in pharmacological sciences.

[46]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[47]  E. Sellers,et al.  Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[48]  Robert C. Smith,et al.  Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia , 2006, Neuropsychopharmacology.

[49]  E. Schadt.  Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[50]  A. Eggers.  A serotonin hypothesis of schizophrenia. , 2013, Medical hypotheses.

[51]  Joseph T. Coyle,et al.  The Glutamatergic Dysfunction Hypothesis for Schizophrenia , 1996, Harvard review of psychiatry.

[52]  Feng Cheng,et al.  Pathways and Networks-Based Analysis of Candidate Genes Associated with Nicotine Addiction , 2015, PloS one.

[53]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[54]  Peilin Jia,et al.  A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case , 2009, Bioinform..

[55]  T. Arinami,et al.  Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia. , 2000, American journal of medical genetics.

[56]  Y. Mineur,et al.  Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction. , 2008, Biochemical Pharmacology.

[57]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[58]  J. Zhu,et al.  Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[59]  C. Robert Cloninger,et al.  Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). , 2001, American journal of medical genetics.

[60]  A. Adan,et al.  Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review , 2017, Neuroscience & Biobehavioral Reviews.

[61]  J. Leon,et al.  A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors , 2005, Schizophrenia Research.

[62]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[63]  A. Morozov,et al.  Rap1 Signaling Prevents L-Type Calcium Channel-Dependent Neurotransmitter Release , 2013, The Journal of Neuroscience.

[64]  J. A. Dani,et al.  Roles of dopamine signaling in nicotine addiction , 2003, Molecular Psychiatry.

[65]  P. Seeman.  Glutamate and dopamine components in schizophrenia. , 2009, Journal of psychiatry & neuroscience : JPN.

[66]  J. Fleiss,et al.  Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers , 1993, Clinical pharmacology and therapeutics.

[67]  T. Shinkai,et al.  Effect of COMT Val108/158Met Genotype on Risk for Polydipsia in Chronic Patients with Schizophrenia , 2014, NeuroMolecular Medicine.

[68]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[69]  V. Parikh,et al.  nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives , 2016, Schizophrenia Research.

[70]  I. Daum,et al.  Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings , 2013, Psychiatry and clinical neurosciences.

[71]  F. Dickerson,et al.  Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity. , 2017, Psychiatric services.

[72]  P. Jia,et al.  SZGR: a comprehensive schizophrenia gene resource , 2009, Molecular Psychiatry.

[73]  Joanna Hauser,et al.  Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia , 2007, Psychiatric genetics.

[74]  J. Kennedy,et al.  Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia , 2010, Annals of human genetics.

[75]  E. Domino,et al.  Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. , 2014, Clinical schizophrenia & related psychoses.